Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer

Topics

Circulating tumor DNA fraction · Circulating tumor DNA fraction · Metastatic castration-resistant prostate cancer (mCRPC) · Metastatic castration-resistant prostate cancer (mCRPC) · liquid biopsy · overall survival · progression-free survival · treatment response prediction · liver metastases · disease burden metrics · ctDNA genotyping · risk stratification · Machine learning prediction model · plasma samples · randomized phase II trials · blood biobanking · clinical prognostic factors · biomarker testing optimization

Share

Share on X

Cite this ranking

Pepkio Research Index (PRI). Topics and Trends in Most Cited Molecular Biology Techniques and Applications Papers, Class of 2026. https://pri.pepkio.com/top-papers/molecular-biology-techniques-and-applications/2026. Accessed 2026-07-24.

Methodology
Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459